Identification of a Novel Aminotetralin Class of HDAC6 and HDAC8 Selective Inhibitors

详细信息    查看全文

• 作者：Guozhi Tang ; Jason C. Wong ; Weixing Zhang ; Zhanguo Wang ; Nan Zhang ; Zhenghong Peng ; Zhenshan Zhang ; Yiping Rong ; Shijie Li ; Meifang Zhang ; Lingjie Yu ; Teng Feng ; Xiongwen Zhang ; Xihan Wu ; Jim Z. Wu ; Li Chen
• 刊名：Journal of Medicinal Chemistry
• 出版年：2014
• 出版时间：October 9, 2014
• 年：2014
• 卷：57
• 期：19
• 页码：8026-8034
• 全文大小：461K
• ISSN：1520-4804

文摘

Herein we report the identification of a novel class of HDAC6 and HDAC8 selective inhibitors through a unique chemistry and phenotypic screening strategy. Tetrahydroisoquinoline 12 was identified as a potent HDAC6 and HDAC8 dual inhibitor from a focused library through cellular tubulin acetylation and p21 induction screening assays. Scaffold hopping from 12 led to the discovery of an aminotetralin class of HDAC inhibitors. In particular, the 3-R stereoisomer 32 showed highly potent inhibition against HDAC6 and HDAC8 with IC₅₀ values of 50 and 80 nM, respectively. Treatment of neuroblastoma BE(2)C cells with 32 resulted in elevated levels of acetylated tubulin, TrkA, and neurite outgrowth with only marginal effects on p21 induction and histone H3 acetylation. Consistent with its weak enzymatic inhibition of HDAC1, 32 showed significantly less cytotoxicity than SAHA and moderately inhibited the growth of myeloma NCI-H929 and OPM-2 cells.